It contains structural changes that extend its half-life and reduce binding to IGF-binding proteins, allowing it to remain active in circulation longer than endogenous IGF-1
Further investigation showed that CPs first reduce the level of skin oxidation, inhibit the expression of the key transcription factor AP-1 (c-Jun and c-Fos), then activate the TGF-/Smad signaling pathway to promote collagen synthesis, inhibit the expression of MMP-1/3 to inhibit collagen degradation, and inhibit skin inflammation to alleviate skin aging in mice
The 12mg total fill supports repeated dial-a-dose injections at 0.25mg, 0.5mg, 0.75mg, 1mg or 2mg per API per shot, mirroring the titration scheme used in Novo Nordisk's clinical programme [1]
Supports energy metabolism and red blood cell formation
-Lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: an mechanistic perspective
Initial effects typically manifest within the first week